Human-important outcomes and EBM during the COVID-19 pandemic The pandemic brought with it an entire new realm of human suffering that is only indirectly related to disease itself—it relates to the societies’ ways of dealing with the illness. We propose that when making decisions about health-care interventions during this and during future pandemics, those “human-important outcomes” are carefully considered.
Publications of the Week, June 29 A digest of noteworthy publications curated by editors from McMaster University. This week’s focus: benefits of comprehensive disease-modifying pharmacologic therapies in patients with heart failure with reduced ejection fraction.
English
Polski
Español
українська
